Cargando…
Use of ibandronate in the prevention of skeletal events in metastatic breast cancer
Bone metastasis from breast cancer often cause significant morbidity including pain, impaired mobility, pathological fracture, and spinal cord compression. Bisphosphonates play an important role in preventing these skeletal related events and are the standard of care for patients with bone metastasi...
Autores principales: | Devitt, Bianca, McLachlan, Sue-Anne |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504065/ https://www.ncbi.nlm.nih.gov/pubmed/18728841 |
Ejemplares similares
-
Ibandronate to treat skeletal-related events and bone pain in metastatic bone disease or multiple myeloma: a meta-analysis of randomised clinical trials
por: Geng, Chun-Jing, et al.
Publicado: (2015) -
Ibandronate: The loading dose concept in the treatment of metastatic bone pain
por: Maier, Gerrit Steffen, et al.
Publicado: (2015) -
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies
por: Body, J J, et al.
Publicado: (2004) -
Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
por: Sambrook, Philip
Publicado: (2007) -
Improving clinical trials using Bayesian adaptive designs: a breast cancer example
por: Hong, Wei, et al.
Publicado: (2022)